Identify the material
The exact extract, composition and delivery format matter.
RESEARCH CONTEXT
Ingredient research, with its limits made clear.
The sources below inform our development questions. They are not clinical studies of ELX-13 and do not establish benefits for the finished drink.
ELX-13 has not established finished-product effects on lifespan, biological ageing, cell regeneration, mood or digestive conditions.
Olive-leaf extract research
A 2013 crossover study in 46 overweight middle-aged men tested a specific olive-leaf extract for 12 weeks. The daily intervention supplied 51.1 mg oleuropein and 9.7 mg hydroxytyrosol.
This was a particular extract used in a particular study population. It was not ELX-13, and its composition is not a final ELX-13 specification.
Saffron-extract research
A 2017 placebo-controlled study examined the specified affron saffron extract over four weeks, including a 28 mg daily group.
Research on that named extract cannot automatically be transferred to another saffron material or to ELX-13. The final ELX-13 extract has not been selected.
Mastic-resin research
A 2010 study in 148 people with functional dyspepsia examined 350 mg of Chios mastic gum three times a day for three weeks.
This was a patient study using a divided daily dose. It does not establish a digestive-treatment claim or a serving instruction for ELX-13.
Understanding vitamin B3
Nicotinamide is a form of vitamin B3. It is distinct from nicotinic acid, nicotinamide riboside, NMN and NAD+.
A nutrient reference or a competitor’s ingredient amount does not establish the final ELX-13 dose or a longevity effect.
How we read the research
Check the study context
Dose, duration and the people studied affect what a result can tell us.
Separate ingredient and product evidence
An ingredient study cannot be presented as an ELX-13 product result.
Current development record
The website follows the ELX-13 master business plan dated 16 September 2026. Final formula, sourcing, packaging, shelf life and label review remain open.
Website aligned with the current development brief
Product pages now distinguish the confirmed 355 ml still format from ingredients and specifications under evaluation. Earlier numerical formula statements have been removed from current product copy.
Content prepared 23 September 2026. Publication occurs when this package is deployed.